Abstract
Several microbial molecules with pathogen-associated molecular patterns stimulate host innate immune responses. The innate immune system plays a crucial role in activating acquired immune response via cytokine production and antigen presentation. Previous studies have shown that Aureobasidium pullulans-cultured fluid (AP-CF), which contains β-glucan, exhibits adjuvant activity and renders mice resistance to influenza A virus infection; however, the underlying mechanism remains elusive. In this study, we investigated the innate immune response to AP-CF. We found that intraperitoneal administration of AP-CF increased the serum level of IL-18 and the number of splenic IFN-γ producing CD4+ cells during influenza A virus infection. The adjuvant effect of AP-CF was distinct from that of alum, which is known to have the ability to stimulate a Th2 immune response. In addition, AP-CF injection barely increased the number of peritoneal neutrophils and inflammatory macrophages, whereas alum injection markedly increased the number of neutrophils and inflammatory macrophages, suggesting that AP-CF is a weak inducer of inflammation compared to alum. AP-CF induced IL-18 production by DC2.4 cells, a dendritic cell line, and by peritoneal exudate cells that include peritoneal macrophages. Collectively, our findings indicate that AP-CF is an adjuvant that promotes the Th1 response during influenza A virus infection.
Keywords: Aureobasidium pullulans; adjuvant; infection; influenza A virus; innate immunity.
© The Authors 2017. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.
Similar articles
- Biological Activity of High-Purity β-1,3-1,6-Glucan Derived from the Black Yeast Aureobasidium pullulans: A Literature Review.Suzuki T, Kusano K, Kondo N, Nishikawa K, Kuge T, Ohno N.Nutrients. 2021 Jan 16;13(1):242. doi: 10.3390/nu13010242.PMID: 33467004Free PMC article.Review.
- β-Glucan derived from Aureobasidium pullulans is effective for the prevention of influenza in mice.Muramatsu D, Iwai A, Aoki S, Uchiyama H, Kawata K, Nakayama Y, Nikawa Y, Kusano K, Okabe M, Miyazaki T.PLoS One. 2012;7(7):e41399. doi: 10.1371/journal.pone.0041399. Epub 2012 Jul 23.PMID: 22844473Free PMC article.
- A small scale study on the effects of oral administration of the β-glucan produced by Aureobasidium pullulans on milk quality and cytokine expressions of Holstein cows, and on bacterial flora in the intestines of Japanese black calves.Uchiyama H, Iwai A, Asada Y, Muramatsu D, Aoki S, Kawata K, Kusano K, Nagashima K, Yasokawa D, Okabe M, Miyazaki T.BMC Res Notes. 2012 Jun 19;5:189. doi: 10.1186/1756-0500-5-189.PMID: 22534338Free PMC article.
- Enhancement of intestinal immune function in mice by β-D-glucan from aureobasidium pullulans ADK-34.Tanioka A, Tanabe K, Hosono A, Kawakami H, Kaminogawa S, Tsubaki K, Hachimura S.Scand J Immunol. 2013 Jul;78(1):61-8. doi: 10.1111/sji.12067.PMID: 23672535
- Interleukin-18 regulates both Th1 and Th2 responses.Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H.Annu Rev Immunol. 2001;19:423-74. doi: 10.1146/annurev.immunol.19.1.423.PMID: 11244043Review.
Cited by
- Biological Activity of High-Purity β-1,3-1,6-Glucan Derived from the Black Yeast Aureobasidium pullulans: A Literature Review.Suzuki T, Kusano K, Kondo N, Nishikawa K, Kuge T, Ohno N.Nutrients. 2021 Jan 16;13(1):242. doi: 10.3390/nu13010242.PMID: 33467004Free PMC article.Review.
- Autoimmune disease associated IFIH1 single nucleotide polymorphism related with IL-18 serum levels in Chinese systemic lupus erythematosus patients.Zhang J, Liu X, Meng Y, Wu H, Wu Y, Yang B, Wang L.Sci Rep. 2018 Jun 21;8(1):9442. doi: 10.1038/s41598-018-27782-7.PMID: 29930297Free PMC article.
- Correlation of interleukin-18 gene polymorphism with the susceptibility of condyloma acuminatum in Chinese population.Wang C, Wei L, Chu W, Yu H, Yu X, Li C.Braz J Infect Dis. 2019 Nov-Dec;23(6):388-394. doi: 10.1016/j.bjid.2019.09.001. Epub 2019 Oct 18.PMID: 31634439Free PMC article.
- Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis.Preethy S, Raghavan K, Dedeepiya VD, Surya Prakash V, Ikewaki N, Ikeue Y, Nagataki M, Iwasaki M, Senthilkumar R, Abraham SJK.Front Immunol. 2022 Jun 27;13:870632. doi: 10.3389/fimmu.2022.870632. eCollection 2022.PMID: 35833122Free PMC article.Review.
References
PMID: 29036651
DOI: 10.1093/jb/mvx062